Advance Search
RONG Fang, WU Feng, ZHOU Jun. Research progress on resistance mechanism of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 134-138. DOI: 10.7619/jcmp.20214525
Citation: RONG Fang, WU Feng, ZHOU Jun. Research progress on resistance mechanism of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 134-138. DOI: 10.7619/jcmp.20214525
shu

Research progress on resistance mechanism of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae

  • 1.

    Respiratory and Critical Care Medicine Department, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, 225000

  • 2.

    Graduate School of Dalian Medical University, Dalian, Liaoning, 116044

More Information
  • Received Date: November 16, 2021
  • Available Online: April 05, 2022
  • Published Date: May 14, 2022
    Graphical Abstract
    • Abstract
  • Klebsiella pneumoniae (KP) is a common pathogen in clinical upper respiratory tract infection. In recent years, with the widespread use of carbapenem antibiotics, the detection rate of carbapenem-resistant Klebsiella pneumoniae (CRKP) has increased year by year. Its multiple drug resistance brings severe challenges to clinical treatment. Tigecycline(TGC) is one of the few drugs with good efficacy against multi-drug-resistant bacteria. This paper reviewed the research progress on the drug-resistant mechanism of TGC-resistant CRKP strain (T-CRKP), in order to provide a basis for preventing and controlling the spread and epidemic of tigecycline-resistant strains.
    • FullText(HTML)
    • References (35)
  • [1]
    SQUIRES K M, NGUYEN M H, SHIELDS R K, et al. Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime-avibactam resistance emerged are not hypermutators[J]. Diagn Microbiol Infect Dis, 2020, 96(3): 114954. doi: 10.1016/j.diagmicrobio.2019.114954
    [2]
    SHAMINA O V, KRYZHANOVSKAYA O A, LAZAREVA A V, et al. Emergence of a ST307 clone carrying a novel insertion element MITEKpn1 in the mgrB gene among carbapenem-resistant Klebsiella pneumoniae from Moscow, Russia[J]. Int J Antimicrob Agents, 2020, 55(2): 105850. doi: 10.1016/j.ijantimicag.2019.11.007
    [3]
    梁武华, 梁敏煜, 周海燕, 等. 耐碳青霉烯类肺炎克雷伯菌耐药监测及分子耐药机制的研究进展[J]. 当代医学, 2021, 27(19): 191-194. doi: 10.3969/j.issn.1009-4393.2021.19.079
    [4]
    陈艳慧, 胡龙华, 钟桥石, 等. 肺炎克雷伯菌临床分布特征及耐药性变迁[J]. 实验与检验医学, 2018, 36(3): 326-329. doi: 10.3969/j.issn.1674-1129.2018.03.010
    [5]
    HU Y M, PING Y T, LI L Q, et al. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients[J]. J Infect Dev Ctries, 2016, 10(3): 208-213. doi: 10.3855/jidc.6697
    [6]
    RAHIM G R, GUPTA N, MAHESHWARI P, et al. Monomicrobial Klebsiella pneumoniae necrotizing fasciitis: an emerging life-threatening entity[J]. Clin Microbiol Infect, 2019, 25(3): 316-323. doi: 10.1016/j.cmi.2018.05.008
    [7]
    毛昳涵. 碳青霉烯耐药肺炎克雷伯菌院内流行及替加环素耐药机制研究[D]. 杭州: 浙江大学, 2019.
    [8]
    REYES J, AGUILAR A C, CAICEDO A. Carbapenem-resistant Klebsiella pneumoniae: microbiology key points for clinical practice[J]. Int J Gen Med, 2019, 12: 437-446. doi: 10.2147/IJGM.S214305
    [9]
    AGYEMAN A A, BERGEN P J, RAO G G, et al. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections[J]. Int J Antimicrob Agents, 2020, 55(1): 105833. doi: 10.1016/j.ijantimicag.2019.10.014
    [10]
    CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae[J]. MMWR Morb Mortal Wkly Rep, 2013, 62(9): 165-170.
    [11]
    胡付品, 郭燕, 朱德妹, 等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2021, 21(4): 377-387. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202104001.htm
    [12]
    张娣. 一株泛耐药肺炎克雷伯菌耐药机制研究[D]. 杭州: 浙江大学, 2020.
    [13]
    DOAN T L, FUNG H B, MEHTA D, et al. Tigecycline: a glycylcycline antimicrobial agent[J]. Clin Ther, 2006, 28(8): 1079-1106. doi: 10.1016/j.clinthera.2006.08.011
    [14]
    郭咸希, 何文, 陈莹, 等. 我院住院患者耐碳青霉烯肺炎克雷伯菌感染的回顾性分析[J]. 中国药师, 2021, 24(2): 317-321. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSG202102023.htm
    [15]
    FRITZENWANKER M, IMIRZALIOGLU C, HEROLD S, et al. Treatment options for carbapenem- resistant gram-negative infections[J]. Dtsch Arztebl Int, 2018, 115(20/21): 345-352.
    [16]
    PAPADIMITRIOU-OLIVGERIS M, BARTZAVALI C, NIKOLOPOULOU A, et al. Impact of tigecycline's MIC in the outcome of critically ill patients with carbapenemase-producing Klebsiella pneumoniae bacteraemia treated with tigecycline monotherapy-validation of 2019's EUCAST proposed breakpoint changes[J]. Antibiotics (Basel), 2020, 9(11): E828. doi: 10.3390/antibiotics9110828
    [17]
    HACKEL M, KAZMIERCZAK K M, HOBAN D J, et al. Assessment of the in vitro activity of ceftazidime-avibactam against multidrug-resistant Klebsiella spp. collected in the INFORM global surveillance study, 2012 to 2014[J]. Antimicrob Agents Chemother, 2016, 60(8): 4677-4683.
    [18]
    KHURSHID M, RASHID A, HUSNAIN M, et al. In-vitro assessment of the therapeutic potential of polymyxins and tigecycline against multidrugresistant Acinetobacter isolates from infected wounds[J]. J Ayub Med Coll Abbottabad, 2020, 32(4): 459-464.
    [19]
    GRIMSEY E M, WESTON N, RICCI V, et al. Overexpression of RamA, which regulates production of the multidrug resistance efflux pump AcrAB-TolC, increases mutation rate and influences drug resistance phenotype[J]. Antimicrob Agents Chemother, 2020, 64(4): e02460-e02419.
    [20]
    SUBHADRA B, KIM J, KIM D H, et al. Local repressor AcrR regulates AcrAB efflux pump required for biofilm formation and virulence in Acinetobacter nosocomialis[J]. Front Cell Infect Microbiol, 2018, 8: 270. doi: 10.3389/fcimb.2018.00270
    [21]
    张娣, 周志慧. 碳青霉烯耐药肺炎克雷伯菌对替加环素的耐药机制研究进展[J]. 世界最新医学信息文摘: 连续型电子期刊, 2020, 20(24): 47-49, 54. doi: 10.3969/j.issn.1671-3141.2020.24.020
    [22]
    LI J, ZHANG H Y, NING J N, et al. The nature and epidemiology of OqxAB, a multidrug efflux pump[J]. Antimicrob Resist Infect Control, 2019, 8: 44. doi: 10.1186/s13756-019-0489-3
    [23]
    NIELSEN L E, SNESRUD E C, ONMUS-LEONE F, et al. IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2014, 58(10): 6151-6156. doi: 10.1128/AAC.03053-14
    [24]
    JUAN C H, HUANG Y W, LIN Y T, et al. Risk factors, outcomes, and mechanisms of tigecycline-nonsusceptible Klebsiella pneumoniae bacteremia[J]. Antimicrob Agents Chemother, 2016, 60(12): 7357-7363. doi: 10.1128/AAC.01503-16
    [25]
    AKIYAMA T, PRESEDO J, KHAN A A. The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolates[J]. Int J Antimicrob Agents, 2013, 42(2): 133-140. doi: 10.1016/j.ijantimicag.2013.04.017
    [26]
    LINKEVICIUS M, SANDEGREN L, ANDERSSON D I. Potential of tetracycline resistance proteins to evolve tigecycline resistance[J]. Antimicrob Agents Chemother, 2016, 60(2): 789-796. doi: 10.1128/AAC.02465-15
    [27]
    FOONG W E, WILHELM J, TAM H K, et al. Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters[J]. J Antimicrob Chemother, 2020, 75(5): 1135-1139. doi: 10.1093/jac/dkaa015
    [28]
    赖宁燕, 虞亦鸣, 邓在春. 碳青霉烯类耐药肺炎克雷伯杆菌耐药机制及治疗策略研究进展[J]. 中国现代医生, 2019, 57(36): 163-168. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201936042.htm
    [29]
    BENDER J K, KLARE I, FLEIGE C, et al. A nosocomial cluster of tigecycline- and vancomycin-resistant Enterococcus faecium isolates and the impact of rpsJ and tet(M) mutations on tigecycline resistance[J]. Microb Drug Resist, 2020, 26(6): 576-582. doi: 10.1089/mdr.2019.0346
    [30]
    BEABOUT K, HAMMERSTROM T G, PEREZ A M, et al. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility[J]. Antimicrob Agents Chemother, 2015, 59(9): 5561-5566. doi: 10.1128/AAC.00547-15
    [31]
    HE F, SHI Q C, FU Y, et al. Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment[J]. Infect Genet Evol, 2018, 66: 188-191. doi: 10.1016/j.meegid.2018.09.025
    [32]
    朱瑞奇, 吴韩, 曾杨梅, 等. 肠杆菌科细菌替加环素耐药机制的研究进展[J]. 江西畜牧兽医杂志, 2020(5): 7-12. doi: 10.3969/j.issn.1004-2342.2020.05.003
    [33]
    LU B, JIANG Y J, MAN M Q, et al. Expression and regulation of 1-acyl-sn-glycerol- 3-phosphate acyltransferases in the epidermis[J]. J Lipid Res, 2005, 46(11): 2448-2457. doi: 10.1194/jlr.M500258-JLR200
    [34]
    LI X, LIU L, JI J, et al. Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase[J]. Eur J Clin Microbiol Infect Dis, 2015, 34(3): 625-631. doi: 10.1007/s10096-014-2272-y
    [35]
    HUANG Y H, CHOU S H, LIANG S W, et al. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan[J]. J Antimicrob Chemother, 2018, 73(8): 2039-2046. doi: 10.1093/jac/dky164
    • Related Articles

  • Related Articles

    [1]LAI Yanling, CAI Dongmei, ZHUO Jingjing, LI Hao, LI Wenhui. Risk factors for postoperative secondary hydrocephalus in patients with severe craniocerebral injury and construction of nomogram risk model[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 94-97, 117. DOI: 10.7619/jcmp.20242442
    [2]YU Lingying, WANG Xiaolei, SHEN Xiaofang, CAO Jing, XU Ji, DU Huaping. Risk factors of aspiration during hospitalization in patients with ischemic stroke and establishment of a predictive model[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 103-108. DOI: 10.7619/jcmp.20240594
    [3]WANG Huili, LI Huijuan, LU Yan, QIN Xiuyu, CHEN Dandan, XU Yun. Risk factors of intraoperative hypothermia in patients undergoing radical thyroidectomy under laparoscopy and the construction of nomogram model[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 29-33. DOI: 10.7619/jcmp.20232740
    [4]WANG Yongxia, CHEN Xiao, LI Mei, JIANG Lijun, DING Hui. Influencing factors of dwarfism in children and construction of the nomogram model[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 92-95. DOI: 10.7619/jcmp.20232434
    [5]SONG Feng, FANG Canjun, HU Jing, CHEN Yi. Risk factors of preoperative deep venous thrombosis in young and middle-aged patients with hip fracture and construction of a Nomogram predictive model[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 32-37. DOI: 10.7619/jcmp.20230579
    [6]YI Yanan, HAN Chongxu, LIANG Chengtong, YANG Mingyu, WANG Mengting. Risk factors identification for prognosis of ovarian cancer patients with lung metastasis and establishment of nomogram[J]. Journal of Clinical Medicine in Practice, 2023, 27(1): 1-8, 15. DOI: 10.7619/jcmp.20223123
    [7]SHAN Qingting, DU Huaping, LU Man, XIE Li, XU Yuan. Nomogram prediction model for repeated fluctuationof symptoms within 24 hours of intravenous thrombolysis with recombinant tissue plasminogen activator in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 23-28. DOI: 10.7619/jcmp.20220023
    [8]DONG Yanping, WANG Jiemin, WANG Yujin, REN Yali, DONG Yucheng, YONG Yanjun, SU Xuandi, WANG Jixiang, SU Nan, WANG Fuli, XIA Duosheng. Construction and evaluation of Nomogram prediction model for postoperative recurrence of pterygium[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 52-56. DOI: 10.7619/jcmp.20214610
    [9]ZHOU Lanmei, JIANG Lijun, ZHU Fengxia, ZHAO Xuemei, JIN Yanting. Analysis in risk factors of respiratory tract infectionin preschool children and construction of nomogram prediction model[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 9-14. DOI: 10.7619/jcmp.20211520
    [10]HU Tingting, GUO Qiu, TANG Weiwei, YANG Huan, LIU Guijun. A Nomogram model establishment for noscomial infection in elderly patients with hypertension and diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 55-60. DOI: 10.7619/jcmp.20210055

  • Cited by

    Periodical cited type(1)

    1. 吴春蕾，杨盼，徐敏，李瑛，王跃涛. 心电图P波离散度及Ⅱ导联P波峰值时间对原发性高血压患者新发心房颤动的预测价值. 实用临床医药杂志. 2024(22): 21-25 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (401) PDF downloads (47) Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return